Heart rate variability-based prediction of early cardiotoxicity in breast-cancer patients treated wi...
Heart rate variability-based prediction of early cardiotoxicity in breast-cancer patients treated with anthracyclines and trastuzumab
About this item
Full title
Author / Creator
Luna-Alcala, Santiago , Espejel-Guzmán, Adrián , Lerma, Claudia , Leon, Paula , Guerra, Enrique C , Fernández, Jose Rodrigo Espinosa , Martinez-Dominguez, Pavel , Serrano-Roman, Javier , Cabello-Ganem, Aldo , Aparicio-Ortiz, Alexis D , Keirns, Candace , Lerma, Abel , Ana-Bayona, Maria Jose Santa and Espinola-Zavaleta, Nilda
Publisher
England: Springer
Journal title
Language
English
Formats
Publication information
Publisher
England: Springer
Subjects
More information
Scope and Contents
Contents
Cardiotoxicity is a recognized complication in breast cancer (BC) patients undergoing chemotherapy with anthracyclines with or without trastuzumab. However, the prognostic value of heart rate variability (HRV) indexes for early cardiotoxicity development remains unknown.
Fifty BC patients underwent TTE assessment before and three months after ch...
Alternative Titles
Full title
Heart rate variability-based prediction of early cardiotoxicity in breast-cancer patients treated with anthracyclines and trastuzumab
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_7f3323e96e5b43418679094989ea81b5
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7f3323e96e5b43418679094989ea81b5
Other Identifiers
ISSN
2057-3804
E-ISSN
2057-3804
DOI
10.1186/s40959-024-00236-y
